AptaBio Therapeutics Inc. (KOSDAQ: 293780)
South Korea flag South Korea · Delayed Price · Currency is KRW
6,310.00
-100.00 (-1.56%)
Nov 15, 2024, 9:00 AM KST

AptaBio Therapeutics Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022
Period Ending
Jun '24 Dec '23 Dec '22
Cash & Equivalents
38,12825,0161,989
Short-Term Investments
6,00019,00015,026
Trading Asset Securities
4,7758,869-
Cash & Short-Term Investments
48,90252,88517,015
Cash Growth
187.41%210.81%-
Other Receivables
160.53366.31224.46
Receivables
2,5362,6593,047
Prepaid Expenses
152.31176.3188.23
Other Current Assets
5,9241,754268.93
Total Current Assets
57,51557,47420,419
Property, Plant & Equipment
4,9485,1295,848
Long-Term Investments
19,68823,77927,885
Other Intangible Assets
49.9261.0937.83
Other Long-Term Assets
3,6563,6751,924
Total Assets
88,75792,51956,114
Accrued Expenses
367.76337.19455.54
Current Portion of Leases
159.8131.08109.73
Current Income Taxes Payable
-1.48-
Other Current Liabilities
1,490348.2474.75
Total Current Liabilities
2,163817.951,040
Long-Term Debt
15,43813,569-
Long-Term Leases
184.49233.45256.3
Other Long-Term Liabilities
17,17613,52454.58
Total Liabilities
38,19131,1563,744
Common Stock
11,14911,14911,149
Additional Paid-In Capital
129,712129,712109,025
Retained Earnings
-91,712-80,713-68,473
Comprehensive Income & Other
897.91696.38668.63
Total Common Equity
50,04760,84552,370
Shareholders' Equity
50,56661,36352,370
Total Liabilities & Equity
88,75792,51956,114
Total Debt
15,78213,934366.03
Net Cash (Debt)
33,12138,95116,649
Net Cash Growth
98.93%133.95%-
Net Cash Per Share
1485.301746.78746.98
Filing Date Shares Outstanding
22.322.322.3
Total Common Shares Outstanding
22.322.322.3
Working Capital
55,35256,65619,379
Book Value Per Share
2244.372728.602348.53
Tangible Book Value
49,99760,78452,332
Tangible Book Value Per Share
2242.132725.862346.83
Land
1,7871,7871,922
Buildings
3,0463,0463,388
Machinery
1,1961,1961,101
Source: S&P Capital IQ. Standard template. Financial Sources.